Improve walking using visual feedback
- Trial ID
- NCT07322939
- Official Title
- Effects of Visual Indicator Exercises for the Trunk and Lower Extremities on Activity and Participation in Parkinson's Disease
- Goal
- Improve walking using visual feedback
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Hasan Kalyoncu University
- Study Type
- INTERVENTIONAL
- Enrollment
- 32 participants
- Conditions
- Parkinson Disease, Balance Impairment, Exercise Training, Postural Control
- Interventions
- Control Group, Visual Feedback Exercise Group
Summary For Families
Researchers want to know whether using visual indicators during trunk and lower limb exercises can improve balance, posture, mobility, and participation in daily life for people with Parkinson's. The program gives real-time visual cues so you can see and correct trunk alignment and weight shifts, with the aim of retraining balance reactions and making gait and functional movements steadier; it is a non-drug rehabilitation approach used alongside your oral antiparkinsonian meds, not a replacement. Outcomes with the visual feedback program are compared to a control group that does the same exercise program without the visual indicators. Adults 18 to 85 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who are on oral antiparkinsonian treatment only can join, while people with major musculoskeletal, cardiovascular, vestibular, other neurological or psychiatric disorders, or poor vision are excluded.
Locations
- Hasan Kalyoncu University, Gaziantep, Şahinbey, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Control Group. Researchers want to know whether using visual indicators during trunk and lower limb exercises can improve balance, posture, mobility, and participation in daily life for people with Parkinson's. The program gives real-time visual cues so you can see and correct trunk alignment and weight shifts, with the aim of retraining balance reactions and making gait and functional movements steadier; it is a non-drug rehabilitation approach used alongside your oral antiparkinsonian meds, not a replacement. Outcomes with the visual feedback program are compared to a control group that does the same exercise program without the visual indicators. Adults 18 to 85 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who are on oral antiparkinsonian treatment only can join, while people with major musculoskeletal, cardiovascular, vestibular, other neurological or psychiatric disorders, or poor vision are excluded.
- Who can participate?
- Participants must be between 18 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 4 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.